Genetic evaluation of severe male factor infertility in Turkey: a cross-sectional study

Sabri Cavkaytar1, Sertaç Batioglu, Mufit Gunel

  • 1Kecioren Education and Research Hospital, Department of Obstetrics and Gynecology, Ankara, Turkey. sabri.cavkaytar@gmail.com

Abstract

Insights

Genetic screening is crucial for infertile men with severe oligozoospermia or nonobstructive azoospermia, as 14% have chromosomal abnormalities or Y chromosome microdeletions.

Area of Science:

  • Human Genetics
  • Reproductive Medicine
  • Infertility Research

Background:

  • Male infertility affects a significant portion of couples seeking reproductive assistance.
  • Severe oligozoospermia and nonobstructive azoospermia are key indicators of potential underlying genetic causes.
  • Understanding genetic factors is vital for accurate diagnosis and effective treatment strategies.

Purpose of the Study:

  • To investigate the prevalence and types of chromosomal abnormalities and Y chromosome microdeletions in infertile males.
  • To explore the correlation between patient clinical characteristics and identified genetic abnormalities.
  • To establish the necessity of genetic screening in specific male infertility populations.

Main Methods:

  • A cohort of 322 infertile men, including those with severe oligozoospermia and nonobstructive azoospermia, was analyzed.
  • Genetic analysis included karyotyping and Polymerase Chain Reaction (PCR) screening for Y chromosome microdeletions.
  • Hormonal assays and semen analyses were performed concurrently.

Main Results:

  • A genetic abnormality was identified in 14% (48/332) of infertile men.
  • Karyotype abnormalities, including Klinefelter's syndrome (7.2%), were detected in 24 cases.
  • Y chromosome microdeletions, primarily in the azoospermia factor (AZF) regions, were found in 6% of patients.

Conclusions:

  • Genetic screening, encompassing karyotype analysis and Y chromosome microdeletion testing, is recommended for all men with nonobstructive azoospermia or severe oligozoospermia.
  • Early identification of genetic abnormalities can guide reproductive management and counseling.
  • This study highlights the significant contribution of genetic factors to severe male infertility.

Related Concept Videos

Infertility in Males01:23

Infertility in Males

Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
Spermatogenesis01:41

Spermatogenesis

Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male reproductive...
Infertility in Females01:28

Infertility in Females

Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of endometrial...